ID   CP46A_HUMAN             Reviewed;         500 AA.
AC   Q9Y6A2; B4DHP8; E7EQG9; Q8N2B0;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Cholesterol 24-hydroxylase;
DE            Short=CH24H;
DE            EC=1.14.14.25 {ECO:0000269|PubMed:18621681};
DE   AltName: Full=Cytochrome P450 46A1;
GN   Name=CYP46A1; Synonyms=CYP46;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=10377398; DOI=10.1073/pnas.96.13.7238;
RA   Lund E.G., Guileyardo J.M., Russell D.W.;
RT   "cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol
RT   homeostasis in the brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:7238-7243(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Amygdala, and Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CHARACTERIZATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=14640697; DOI=10.1021/bi035512f;
RA   Mast N., Norcross R., Andersson U., Shou M., Nakayama K.,
RA   Bjoerkhem I., Pikuleva I.A.;
RT   "Broad substrate specificity of human cytochrome P450 46A1 which
RT   initiates cholesterol degradation in the brain.";
RL   Biochemistry 42:14284-14292(2003).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 51-500 IN COMPLEX WITH HEME
RP   AND CHOLESTEROL 3-SULFATE, FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=18621681; DOI=10.1073/pnas.0803717105;
RA   Mast N., White M.A., Bjorkhem I., Johnson E.F., Stout C.D.,
RA   Pikuleva I.A.;
RT   "Crystal structures of substrate-bound and substrate-free cytochrome
RT   P450 46A1, the principal cholesterol hydroxylase in the brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:9546-9551(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 51-500 IN COMPLEXES WITH HEME
RP   AND INHIBITORS, FUNCTION, AND COFACTOR.
RX   PubMed=20667828; DOI=10.1074/jbc.M110.143313;
RA   Mast N., Charvet C., Pikuleva I.A., Stout C.D.;
RT   "Structural basis of drug binding to CYP46A1, an enzyme that controls
RT   cholesterol turnover in the brain.";
RL   J. Biol. Chem. 285:31783-31795(2010).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 51-500 IN COMPLEXES WITH HEME
RP   AND THE INHIBITOR BICALUTAMIDE, AND COFACTOR.
RX   PubMed=23288837; DOI=10.1074/jbc.M112.438754;
RA   Mast N., Zheng W., Stout C.D., Pikuleva I.A.;
RT   "Binding of a cyano- and fluoro-containing drug bicalutamide to
RT   cytochrome P450 46A1: unusual features and spectral response.";
RL   J. Biol. Chem. 288:4613-4624(2013).
CC   -!- FUNCTION: Involved in the turnover of cholesterol. It converts
CC       cholesterol into 24S-hydroxycholesterol and, to a lesser extent,
CC       25-hydroxycholesterol. Has also activity with xenobiotic
CC       compounds, such as clotrimazole. {ECO:0000269|PubMed:18621681,
CC       ECO:0000269|PubMed:20667828}.
CC   -!- CATALYTIC ACTIVITY: Cholesterol + [reduced NADPH--hemoprotein
CC       reductase] + O(2) = (24S)-cholest-5-ene-3-beta,24-diol + [oxidized
CC       NADPH--hemoprotein reductase] + H(2)O.
CC       {ECO:0000269|PubMed:18621681}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:18621681,
CC         ECO:0000269|PubMed:20667828, ECO:0000269|PubMed:23288837};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.2 uM for 24(S)-hydroxycholesterol
CC         {ECO:0000269|PubMed:14640697};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein. Microsome membrane; Single-pass membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y6A2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6A2-2; Sequence=VSP_053859;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9Y6A2-3; Sequence=VSP_053858, VSP_053860;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain. The mRNA was broadly
CC       distributed with higher levels in gray matter zones and lower
CC       levels in regions rich in white matter. Not detected in fetal
CC       sample but its expression increases linearly with age.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF094480; AAD41244.1; -; mRNA.
DR   EMBL; AK090886; BAC03539.1; -; mRNA.
DR   EMBL; AK295216; BAG58210.1; -; mRNA.
DR   EMBL; AL136000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160313; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022539; AAH22539.1; -; mRNA.
DR   CCDS; CCDS9954.1; -. [Q9Y6A2-1]
DR   RefSeq; NP_006659.1; NM_006668.1. [Q9Y6A2-1]
DR   UniGene; Hs.25121; -.
DR   PDB; 2Q9F; X-ray; 1.90 A; A=51-500.
DR   PDB; 2Q9G; X-ray; 2.40 A; A=51-500.
DR   PDB; 3MDM; X-ray; 1.60 A; A=51-500.
DR   PDB; 3MDR; X-ray; 2.00 A; A/B=51-500.
DR   PDB; 3MDT; X-ray; 2.30 A; A/B=51-500.
DR   PDB; 3MDV; X-ray; 2.40 A; A/B=51-500.
DR   PDB; 4ENH; X-ray; 2.50 A; A=51-500.
DR   PDB; 4FIA; X-ray; 2.10 A; A=51-500.
DR   PDB; 4J14; X-ray; 2.50 A; A=51-500.
DR   PDBsum; 2Q9F; -.
DR   PDBsum; 2Q9G; -.
DR   PDBsum; 3MDM; -.
DR   PDBsum; 3MDR; -.
DR   PDBsum; 3MDT; -.
DR   PDBsum; 3MDV; -.
DR   PDBsum; 4ENH; -.
DR   PDBsum; 4FIA; -.
DR   PDBsum; 4J14; -.
DR   ProteinModelPortal; Q9Y6A2; -.
DR   SMR; Q9Y6A2; -.
DR   BioGrid; 116069; 2.
DR   IntAct; Q9Y6A2; 1.
DR   STRING; 9606.ENSP00000261835; -.
DR   SwissLipids; SLP:000001220; -. [Q9Y6A2-1]
DR   iPTMnet; Q9Y6A2; -.
DR   PhosphoSitePlus; Q9Y6A2; -.
DR   BioMuta; CYP46A1; -.
DR   DMDM; 12585217; -.
DR   PaxDb; Q9Y6A2; -.
DR   PeptideAtlas; Q9Y6A2; -.
DR   PRIDE; Q9Y6A2; -.
DR   Ensembl; ENST00000261835; ENSP00000261835; ENSG00000036530. [Q9Y6A2-1]
DR   Ensembl; ENST00000380228; ENSP00000369577; ENSG00000036530. [Q9Y6A2-2]
DR   GeneID; 10858; -.
DR   KEGG; hsa:10858; -.
DR   UCSC; uc001ygo.4; human. [Q9Y6A2-1]
DR   CTD; 10858; -.
DR   DisGeNET; 10858; -.
DR   GeneCards; CYP46A1; -.
DR   HGNC; HGNC:2641; CYP46A1.
DR   HPA; HPA040702; -.
DR   MIM; 604087; gene.
DR   neXtProt; NX_Q9Y6A2; -.
DR   OpenTargets; ENSG00000036530; -.
DR   PharmGKB; PA27117; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118816; -.
DR   HOGENOM; HOG000290190; -.
DR   HOVERGEN; HBG102502; -.
DR   InParanoid; Q9Y6A2; -.
DR   KO; K07440; -.
DR   OMA; CTLQPRG; -.
DR   OrthoDB; EOG091G0AII; -.
DR   PhylomeDB; Q9Y6A2; -.
DR   TreeFam; TF352037; -.
DR   BRENDA; 1.14.13.98; 2681.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   SABIO-RK; Q9Y6A2; -.
DR   ChiTaRS; CYP46A1; human.
DR   EvolutionaryTrace; Q9Y6A2; -.
DR   GeneWiki; CYP46A1; -.
DR   GenomeRNAi; 10858; -.
DR   PRO; PR:Q9Y6A2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000036530; -.
DR   CleanEx; HS_CYP46A1; -.
DR   ExpressionAtlas; Q9Y6A2; baseline and differential.
DR   Genevisible; Q9Y6A2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033781; F:cholesterol 24-hydroxylase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0008395; F:steroid hydroxylase activity; TAS:ProtInc.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006707; P:cholesterol catabolic process; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0016125; P:sterol metabolic process; TAS:Reactome.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol metabolism;
KW   Complete proteome; Endoplasmic reticulum; Heme; Iron;
KW   Lipid metabolism; Membrane; Metal-binding; Microsome; Monooxygenase;
KW   NADP; Oxidoreductase; Reference proteome; Steroid metabolism;
KW   Sterol metabolism; Transmembrane; Transmembrane helix.
FT   CHAIN         1    500       Cholesterol 24-hydroxylase.
FT                                /FTId=PRO_0000051994.
FT   TRANSMEM      3     23       Helical. {ECO:0000255}.
FT   COMPBIAS    493    499       Poly-Pro.
FT   METAL       437    437       Iron (heme axial ligand).
FT   VAR_SEQ       1    153       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053858.
FT   VAR_SEQ       1     97       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053859.
FT   VAR_SEQ     383    392       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053860.
FT   HELIX        60     71       {ECO:0000244|PDB:3MDM}.
FT   STRAND       73     79       {ECO:0000244|PDB:3MDM}.
FT   STRAND       82     87       {ECO:0000244|PDB:3MDM}.
FT   HELIX        90     97       {ECO:0000244|PDB:3MDM}.
FT   HELIX       106    113       {ECO:0000244|PDB:3MDM}.
FT   STRAND      118    121       {ECO:0000244|PDB:3MDM}.
FT   TURN        125    127       {ECO:0000244|PDB:3MDM}.
FT   HELIX       131    141       {ECO:0000244|PDB:3MDM}.
FT   HELIX       142    145       {ECO:0000244|PDB:3MDM}.
FT   HELIX       147    151       {ECO:0000244|PDB:3MDM}.
FT   HELIX       154    170       {ECO:0000244|PDB:3MDM}.
FT   STRAND      173    176       {ECO:0000244|PDB:3MDM}.
FT   HELIX       180    197       {ECO:0000244|PDB:3MDM}.
FT   HELIX       203    205       {ECO:0000244|PDB:3MDM}.
FT   HELIX       209    227       {ECO:0000244|PDB:3MDM}.
FT   HELIX       230    232       {ECO:0000244|PDB:3MDM}.
FT   HELIX       234    236       {ECO:0000244|PDB:3MDM}.
FT   HELIX       237    266       {ECO:0000244|PDB:3MDM}.
FT   HELIX       275    282       {ECO:0000244|PDB:3MDM}.
FT   TURN        283    285       {ECO:0000244|PDB:2Q9F}.
FT   STRAND      287    289       {ECO:0000244|PDB:3MDM}.
FT   HELIX       290    302       {ECO:0000244|PDB:3MDM}.
FT   HELIX       305    318       {ECO:0000244|PDB:3MDM}.
FT   HELIX       322    335       {ECO:0000244|PDB:3MDM}.
FT   TURN        336    338       {ECO:0000244|PDB:3MDM}.
FT   HELIX       344    349       {ECO:0000244|PDB:3MDM}.
FT   HELIX       351    363       {ECO:0000244|PDB:3MDM}.
FT   STRAND      370    374       {ECO:0000244|PDB:3MDM}.
FT   STRAND      378    380       {ECO:0000244|PDB:3MDM}.
FT   STRAND      383    385       {ECO:0000244|PDB:3MDM}.
FT   STRAND      387    393       {ECO:0000244|PDB:3MDM}.
FT   HELIX       395    399       {ECO:0000244|PDB:3MDM}.
FT   TURN        402    404       {ECO:0000244|PDB:3MDM}.
FT   STRAND      405    407       {ECO:0000244|PDB:3MDM}.
FT   HELIX       413    416       {ECO:0000244|PDB:3MDM}.
FT   STRAND      424    426       {ECO:0000244|PDB:3MDM}.
FT   HELIX       433    435       {ECO:0000244|PDB:3MDM}.
FT   HELIX       440    457       {ECO:0000244|PDB:3MDM}.
FT   STRAND      458    462       {ECO:0000244|PDB:3MDM}.
FT   STRAND      470    480       {ECO:0000244|PDB:3MDM}.
FT   STRAND      483    488       {ECO:0000244|PDB:3MDM}.
SQ   SEQUENCE   500 AA;  56821 MW;  AB9307749D9E5FDA CRC64;
     MSPGLLLLGS AVLLAFGLCC TFVHRARSRY EHIPGPPRPS FLLGHLPCFW KKDEVGGRVL
     QDVFLDWAKK YGPVVRVNVF HKTSVIVTSP ESVKKFLMST KYNKDSKMYR ALQTVFGERL
     FGQGLVSECN YERWHKQRRV IDLAFSRSSL VSLMETFNEK AEQLVEILEA KADGQTPVSM
     QDMLTYTAMD ILAKAAFGME TSMLLGAQKP LSQAVKLMLE GITASRNTLA KFLPGKRKQL
     REVRESIRFL RQVGRDWVQR RREALKRGEE VPADILTQIL KAEEGAQDDE GLLDNFVTFF
     IAGHETSANH LAFTVMELSR QPEIVARLQA EVDEVIGSKR YLDFEDLGRL QYLSQVLKES
     LRLYPPAWGT FRLLEEETLI DGVRVPGNTP LLFSTYVMGR MDTYFEDPLT FNPDRFGPGA
     PKPRFTYFPF SLGHRSCIGQ QFAQMEVKVV MAKLLQRLEF RLVPGQRFGL QEQATLKPLD
     PVLCTLRPRG WQPAPPPPPC
//
